| __timestamp | ACADIA Pharmaceuticals Inc. | MannKind Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 32748000 | 79383000 |
| Thursday, January 1, 2015 | 90804000 | 108402000 |
| Friday, January 1, 2016 | 186456000 | 46928000 |
| Sunday, January 1, 2017 | 255062000 | 74959000 |
| Monday, January 1, 2018 | 265758000 | 79716000 |
| Tuesday, January 1, 2019 | 325638000 | 74669000 |
| Wednesday, January 1, 2020 | 388661000 | 59040000 |
| Friday, January 1, 2021 | 396028000 | 77417000 |
| Saturday, January 1, 2022 | 369090000 | 91473000 |
| Sunday, January 1, 2023 | 402466000 | 94314000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. Over the past decade, ACADIA Pharmaceuticals Inc. and MannKind Corporation have taken different paths in optimizing these costs. From 2014 to 2023, ACADIA's SG&A expenses surged by over 1,100%, peaking at approximately $402 million in 2023. This reflects their aggressive expansion and investment in administrative capabilities. In contrast, MannKind Corporation maintained a more conservative approach, with their SG&A expenses increasing by just 19% over the same period, reaching around $94 million in 2023. This strategic restraint may indicate a focus on lean operations. As investors and industry watchers analyze these trends, the question remains: which strategy will yield better long-term returns? The data suggests that while ACADIA is betting on growth, MannKind is prioritizing efficiency.
Merck & Co., Inc. vs MannKind Corporation: SG&A Expense Trends
Selling, General, and Administrative Costs: Sanofi vs ACADIA Pharmaceuticals Inc.
Bristol-Myers Squibb Company or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
argenx SE vs MannKind Corporation: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Catalent, Inc. and MannKind Corporation
Jazz Pharmaceuticals plc or MannKind Corporation: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Amneal Pharmaceuticals, Inc. or MannKind Corporation
Who Optimizes SG&A Costs Better? Xenon Pharmaceuticals Inc. or ACADIA Pharmaceuticals Inc.
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and MiMedx Group, Inc.
HUTCHMED (China) Limited and MannKind Corporation: SG&A Spending Patterns Compared
Operational Costs Compared: SG&A Analysis of Arrowhead Pharmaceuticals, Inc. and MannKind Corporation
Operational Costs Compared: SG&A Analysis of Geron Corporation and MannKind Corporation